CD38 and acute myeloid leukemia: Also our results were in agreement with the results of Wilson et al. and le Viseur et al. [20–21] who reported that there was a correlation between CD38 expression and MRD status, so that AML patients with leukemic blasts expressing CD38 were more likely to be MRD positive.